ChemicalBook > Product Catalog >Biochemical Engineering >Nucleoside drugs >Deoxynucleotides and their analogs >5'-Deoxy-5-fluorocytidine

5'-Deoxy-5-fluorocytidine

5'-Deoxy-5-fluorocytidine Suppliers list
Company Name: Hebei Chuanghai Biotechnology Co., Ltd
Tel: +8615350571055
Email: Sibel@chuanghaibio.com
Products Intro: Product Name:5'-Deoxy-5-fluorocytidine
CAS:66335-38-4
Purity:99% Package:1KG;10.00;USD
Company Name: Hangzhou Measure Life Technology Co., LTD
Tel: +8613343730176
Email: 2924244016@qq.com
Products Intro: Product Name:5'-Deoxy-5-Fluorocytidine
CAS:66335-38-4
Purity:99% Package:1kg
Company Name: Capot Chemical Co.,Ltd.
Tel: +86-(0)57185586718; +8613336195806
Email: sales@capot.com
Products Intro: Product Name:5'-Deoxy-5-fluorocytidine
CAS:66335-38-4
Purity:98%(Min,HPLC) Package:100g;1kg;5kg,10kg,25kg,50kg
Company Name: Beijing Cooperate Pharmaceutical Co.,Ltd
Tel: 010-60279497
Email: sales01@cooperate-pharm.com
Products Intro: Product Name:5'-Deoxy-5-fluorocytidine
CAS:66335-38-4
Purity:98% Package:100G;1KG;5KG;10KG;25KG;50KG;100KG
Company Name: Henan Tianfu Chemical Co.,Ltd.
Tel: +86-0371-55170693 +86-19937530512
Email: info@tianfuchem.com
Products Intro: Product Name:5'-Deoxy-5-fluorocytidine
CAS:66335-38-4
Purity:99% Package:25KG;5KG;1KG

5'-Deoxy-5-fluorocytidine manufacturers

5'-Deoxy-5-fluorocytidine Basic information
Product Name:5'-Deoxy-5-fluorocytidine
Synonyms:5'-DFCR;5'-Deoxy-5-fluoro-D-cytidine;5''-DEOXY-5-FLUOROCYTIDINE (5''-DFCR);5-Fluoro-5’-deoxycytidine, 5’-DFCR;Capecitabine Related Compound A (10 mg) (5'-deoxy-5-fluorocytidine);5'-Deoxy-5-fluorocytidin;CAPECITABINE related substance USP A;Deoxy-5-fluorocytidine-D2
CAS:66335-38-4
MF:C9H12FN3O4
MW:245.21
EINECS:690-482-4
Product Categories:Heterocycles;Bases & Related Reagents;Nucleotides
Mol File:66335-38-4.mol
5'-Deoxy-5-fluorocytidine Structure
5'-Deoxy-5-fluorocytidine Chemical Properties
Melting point 196-198°C
Boiling point 437.9±55.0 °C(Predicted)
density 1.84±0.1 g/cm3(Predicted)
storage temp. Keep in dark place,Sealed in dry,Room Temperature
solubility DMSO (Slightly), Methanol (Slightly)
pka13.65±0.70(Predicted)
form Solid
color White to Light Beige
Stability:HYGROSCOPIC
Major Applicationpharmaceutical small molecule
InChI1S/C9H12FN3O4/c1-3-5(14)6(15)8(17-3)13-2-4(10)7(11)12-9(13)16/h2-3,5-6,8,14-15H,1H3,(H2,11,12,16)/t3-,5-,6-,8-/m1/s1
InChIKeyYSNABXSEHNLERR-ZIYNGMLESA-N
SMILESFC1=CN(C(=O)N=C1N)[C@@H]2O[C@@H]([C@H]([C@H]2O)O)C
CAS DataBase Reference66335-38-4(CAS DataBase Reference)
Safety Information
Hazard Codes Xn,Xi
Risk Statements 20/21/22-36/37/38
Safety Statements 26-36-37/39-24/25
WGK Germany WGK 3
HS Code 29349990
Storage Class11 - Combustible Solids
MSDS Information
5'-Deoxy-5-fluorocytidine Usage And Synthesis
Chemical PropertiesWhite Solid
UsesA metabolite of Capecitabine.
DefinitionChEBI: 5'-Deoxy-5-fluorocytidine is a N-glycosyl compound.
Synthesis
Capecitabine

154361-50-9

5'-Deoxy-5-fluorocytidine

66335-38-4

1. Pentyl (1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl)carbamate (capecitabine, 4.5 g, 12.5 mmol) was suspended with potassium carbonate (8.8 g, 63.77 mmol) in methanol (250 mL) and N,N- dimethylformamide (DMF, 10 mL). The mixture was heated to reflux for 24 hours. Upon completion of the reaction, the reaction solution was cooled and concentrated to dryness under reduced pressure at below 45 °C. The residue was dissolved in hot methanol, filtered and washed with hot methanol. The filtrate was pre-adsorbed on silica gel and purified by fast column chromatography using 50% methanol/ethyl acetate as eluent to afford 1-[3,4-dihydroxy-5-methyltetrahydrofuran-2-yl]-4-amino-1H-pyrimidin-2-one (3.0 g, 90% yield). 2. The above product (3.0 g) was suspended in chloroform (125 mL) and heated to 50 °C. The product (3.0 g) was added to the mixture. Acetic acid (2 mL, 34 mmol) and acetyl chloride (20 mL, 206 mmol) were added sequentially and stirred at 50 °C for 7 hours, followed by continued stirring at 20 °C for 72 hours. At the end of the reaction, ether (100 mL) was added, the solid was collected by filtration and washed with ether to afford 1-[3,4-diacetoxy-5-methyltetrahydrofuran-2-yl]-4-amino-1H-pyrimidin-2-one hydrochloride (4.0 g, 90% yield). 3. The above hydrochloride (2.07 g, 5.7 mmol) was dissolved in pyridine (1.4 mL, 17.4 mmol) and dichloromethane (DCM, 15 mL) with 5-nitrothiophen-2-ylmethanol (1.47 g, 9.3 mmol). A 2M toluene solution of phosgene (3.6 mL, 7.2 mmol) was slowly added at 0 °C and stirred for 2.5 h. After 2.5 h, the same amount of phosgene solution was added again and stirring was continued for 2 h at 0 °C, followed by 18 h of refrigeration. The reaction solution was partitioned with ethyl acetate and brine, the aqueous phase was extracted with ethyl acetate, the organic phases were combined, dried and concentrated under reduced pressure. The residue was purified by silica gel column chromatography with 2% methanol/DCM as eluent to give an off-white foamy product (400 mg, 14% yield). Thin layer chromatography (TLC) showed Rf=0.45 (2% methanol/ethyl acetate as unfolding agent). Liquid chromatography-mass spectrometry (LC-MS) analysis showed a retention time of 4.68 min (TFA 20-50% gradient) and a mass m/z of 201/159/143. nuclear magnetic resonance hydrogen spectra (1H NMR, 500 MHz, DMSO-d6) δ 11.20 (1H, broad single peak, NH), 8.3 (1H, broad peak, NCH=CF). 8.05 (1H, single peak, HarH), 7.30 (1H, single peak, HarH), 5.80 (1H, single peak, NCHO), 5.42 (3H, multiple peaks, HarCH2OCONH, CHOAc), 5.15 (1H, single peak, CHOAc), 4.05 (1H, multiple peaks, OCHCH3), 3.45 (2H, multiple peak, 2×CHOAc), 2.48 (3H, single peak, OAc), 2.05 (3H, single peak, OAc), 1.37 (3H, single peak, OCHCH3) ppm.

References[1] Patent: WO2006/32921, 2006, A1. Location in patent: Page/Page column 37-38
Tag:5'-Deoxy-5-fluorocytidine(66335-38-4) Related Product Information
5-Fluorocytidine 5-Azacytidine Chenodeoxycholic acid Cytidine-5'-triphosphate disodium salt dihydrate Cytarabine Fluorocytosine 1-beta-D-Arabinofuranosylcytosine hydrochloride 2',3'-Di-O-acetyl-5'-deoxy-5-fuluro-D-cytidine 5'-deoxy-5-fluore-N-[(pentoyloxy)carbonyl]cytidine 2',3'-diacetate Ursodeoxycholic acid Doxifluridine 1,2,3-Triacetyl-5-deoxy-D-ribose 2'-Deoxycytidine monohydrate 3'-O-(5'-Deoxy-α-D-ribofuranosyl) Capecitabine 2'-O-(5'-Deoxy-β-D-ribofuranosyl) Capecitabine CAPECITABINE related substance USP 5'-Deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine 5'-Deoxy-5-fluoro-N4-(isopentyloxycarbonyl)cytidine